Cargando…
Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG(4) response
BACKGROUND: BM32, a grass pollen allergy vaccine containing four recombinant fusion proteins consisting of hepatitis B-derived PreS and hypoallergenic peptides from the major timothy grass pollen allergens adsorbed on aluminium hydroxide has been shown to be safe and to improve clinical symptoms of...
Autores principales: | Eckl-Dorna, Julia, Weber, Milena, Stanek, Victoria, Linhart, Birgit, Ristl, Robin, Waltl, Eva E., Villazala-Merino, Sergio, Hummel, Andrea, Focke-Tejkl, Margarete, Froeschel, Renate, Neubauer, Angela, Henning, Rainer, Perkmann, Thomas, Valenta, Rudolf, Niederberger, Verena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921329/ https://www.ncbi.nlm.nih.gov/pubmed/31786130 http://dx.doi.org/10.1016/j.ebiom.2019.11.006 |
Ejemplares similares
-
Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines
por: Weber, Milena, et al.
Publicado: (2017) -
Antibody Conjugates Bispecific for Pollen Allergens and ICAM-1 with Potential to Prevent Epithelial Allergen Transmigration and Rhinovirus Infection
por: Weichwald, Christina, et al.
Publicado: (2023) -
Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32
por: Niederberger, Verena, et al.
Publicado: (2018) -
Allergen Microarray Indicates Pooideae Sensitization in Brazilian Grass Pollen Allergic Patients
por: Moreira, Priscila Ferreira de Sousa, et al.
Publicado: (2015) -
A B Cell Epitope Peptide Derived from the Major Grass Pollen Allergen Phl p 1 Boosts Allergen-Specific Secondary Antibody Responses without Allergen-Specific T Cell Help
por: Narayanan, Meena, et al.
Publicado: (2017)